{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T01:45:24Z","timestamp":1791769524146,"version":"4.3.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"DOI":"10.1007\/s11701-026-04020-1","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T01:28:59Z","timestamp":1791768539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond feasibility: an oncology-first framework for defining the role of robot-assisted surgery in ovarian cancer\u2014patient selection, surgical adequacy, and conversion pathways"],"prefix":"10.1007","volume":"20","author":[{"given":"Gang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"4020_CR1","doi-asserted-by":"publisher","unstructured":"Ledermann JA, Matias-Guiu X, Amant F et al (2024) ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol 35(3):248\u2013266. https:\/\/doi.org\/10.1016\/j.annonc.2023.11.015","DOI":"10.1016\/j.annonc.2023.11.015"},{"key":"4020_CR2","doi-asserted-by":"publisher","unstructured":"Gaillard S, Lacchetti C, Armstrong DK et al (2025) Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: ASCO guideline update. J Clin Oncol 43(7):868\u2013891. https:\/\/doi.org\/10.1200\/JCO-24-02589","DOI":"10.1200\/JCO-24-02589"},{"key":"4020_CR3","doi-asserted-by":"publisher","unstructured":"Querleu D, Planchamp F, Chiva L et al (2016) European Society of Gynaecologic Oncology quality indicators for advanced ovarian cancer surgery. Int J Gynecol Cancer 26(7):1354\u20131363. https:\/\/doi.org\/10.1097\/IGC.0000000000000767","DOI":"10.1097\/IGC.0000000000000767"},{"key":"4020_CR4","doi-asserted-by":"publisher","unstructured":"Fotopoulou C, Concin N, Planchamp F et al (2020) Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update. Int J Gynecol Cancer 30(4):436\u2013440. https:\/\/doi.org\/10.1136\/ijgc-2020-001248","DOI":"10.1136\/ijgc-2020-001248"},{"key":"4020_CR5","doi-asserted-by":"publisher","unstructured":"Fotopoulou C, Planchamp F, Aytulu T et al (2021) European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery. Int J Gynecol Cancer 31(9):1199\u20131206. https:\/\/doi.org\/10.1136\/ijgc-2021-002951","DOI":"10.1136\/ijgc-2021-002951"},{"key":"4020_CR6","doi-asserted-by":"publisher","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20(5):1248\u20131259. https:\/\/doi.org\/10.1200\/JCO.2002.20.5.1248","DOI":"10.1200\/JCO.2002.20.5.1248"},{"key":"4020_CR7","doi-asserted-by":"publisher","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer. Cancer 115(6):1234\u20131244. https:\/\/doi.org\/10.1002\/cncr.24149","DOI":"10.1002\/cncr.24149"},{"key":"4020_CR8","doi-asserted-by":"publisher","unstructured":"Chang SJ, Bristow RE (2012) Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining \u2018optimal\u2019 residual disease. Gynecol Oncol 125(2):483\u2013492. https:\/\/doi.org\/10.1016\/j.ygyno.2012.02.024","DOI":"10.1016\/j.ygyno.2012.02.024"},{"key":"4020_CR9","doi-asserted-by":"publisher","unstructured":"Kim JH, Kim SI, Park EY et al (2023) Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: a systematic review and meta-analysis. Gynecol Oncol 179:24\u201332. https:\/\/doi.org\/10.1016\/j.ygyno.2023.10.018","DOI":"10.1016\/j.ygyno.2023.10.018"},{"key":"4020_CR10","doi-asserted-by":"publisher","unstructured":"Horowitz NS, Miller A, Rungruang B et al (2015) Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin Oncol 33(8):937\u2013943. https:\/\/doi.org\/10.1200\/JCO.2014.56.3106","DOI":"10.1200\/JCO.2014.56.3106"},{"key":"4020_CR11","doi-asserted-by":"publisher","unstructured":"Gallotta V, Cicero C, Conte C et al (2017) Robotic versus laparoscopic staging for early ovarian cancer: a case-matched control study. J Minim Invasive Gynecol 24(2):293\u2013298. https:\/\/doi.org\/10.1016\/j.jmig.2016.11.004","DOI":"10.1016\/j.jmig.2016.11.004"},{"key":"4020_CR12","doi-asserted-by":"publisher","unstructured":"Bellia A, Vitale SG, Lagan\u00e0 AS et al (2016) Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet 294(3):615\u2013622. https:\/\/doi.org\/10.1007\/s00404-016-4087-9","DOI":"10.1007\/s00404-016-4087-9"},{"key":"4020_CR13","doi-asserted-by":"publisher","unstructured":"Brown JV 3rd, Mendivil AA, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH (2014) The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer. Int J Gynecol Cancer 24(8):1493\u20131498. https:\/\/doi.org\/10.1097\/IGC.0000000000000224","DOI":"10.1097\/IGC.0000000000000224"},{"key":"4020_CR14","doi-asserted-by":"publisher","unstructured":"Fornalik H, Brooks H, Moore ES et al (2015) Hand-assisted robotic surgery for staging of ovarian cancer and uterine cancers with high risk of peritoneal spread: a retrospective cohort study. Int J Gynecol Cancer 25(8):1488\u20131493. https:\/\/doi.org\/10.1097\/IGC.0000000000000508","DOI":"10.1097\/IGC.0000000000000508"},{"key":"4020_CR15","doi-asserted-by":"publisher","unstructured":"Gallotta V, Jeong SY, Conte C et al (2021) Minimally invasive surgical staging for early stage ovarian cancer: a long-term follow up. Eur J Surg Oncol 47(7):1698\u20131704. https:\/\/doi.org\/10.1016\/j.ejso.2021.01.033","DOI":"10.1016\/j.ejso.2021.01.033"},{"key":"4020_CR16","doi-asserted-by":"publisher","unstructured":"Ditto A, Bogani G, Martinelli F et al (2017) Minimally invasive surgical staging for ovarian carcinoma: a propensity-matched comparison with traditional open surgery. J Minim Invasive Gynecol 24(1):98\u2013102. https:\/\/doi.org\/10.1016\/j.jmig.2016.09.018","DOI":"10.1016\/j.jmig.2016.09.018"},{"key":"4020_CR17","doi-asserted-by":"publisher","unstructured":"Uwins C, Assalaarachchi H, Bennett K et al (2024) MIRRORS: a prospective cohort study assessing the feasibility of robotic interval debulking surgery for advanced-stage ovarian cancer. Int J Gynecol Cancer 34(6):886\u2013897. https:\/\/doi.org\/10.1136\/ijgc-2024-005265","DOI":"10.1136\/ijgc-2024-005265"},{"key":"4020_CR18","doi-asserted-by":"publisher","unstructured":"Carbajal-Mamani SL, Schweer D, Markham MJ et al (2020) Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study. Obstet Gynecol Sci 63(2):150\u2013157. https:\/\/doi.org\/10.5468\/ogs.2020.63.2.150","DOI":"10.5468\/ogs.2020.63.2.150"},{"key":"4020_CR19","doi-asserted-by":"publisher","unstructured":"Abitbol J, Gotlieb W, Zeng Z et al (2019) Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy. Int J Gynecol Cancer 29(9):1341\u20131347. https:\/\/doi.org\/10.1136\/ijgc-2019-000413","DOI":"10.1136\/ijgc-2019-000413"},{"key":"4020_CR20","doi-asserted-by":"publisher","unstructured":"Zhang Y, Grant MS, Zhang X et al (2021) Comparing laparotomy with robot-assisted interval debulking surgery for patients with advanced epithelial ovarian cancer receiving neoadjuvant chemotherapy. J Minim Invasive Gynecol 28(6):1237\u20131243. https:\/\/doi.org\/10.1016\/j.jmig.2020.11.015","DOI":"10.1016\/j.jmig.2020.11.015"},{"key":"4020_CR21","doi-asserted-by":"publisher","unstructured":"Van Trappen P, de Cuypere E, Claes N (2023) Robotic surgery in early and advanced ovarian cancer: case selection for surgical staging and interval debulking surgery. Eur J Obstet Gynecol Reprod Biol 280:7\u201311. https:\/\/doi.org\/10.1016\/j.ejogrb.2022.11.005","DOI":"10.1016\/j.ejogrb.2022.11.005"},{"key":"4020_CR22","doi-asserted-by":"publisher","unstructured":"Psomiadou V, Prodromidou A, Fotiou A et al (2021) Robotic interval debulking surgery for advanced epithelial ovarian cancer: current challenge or future direction? A systematic review. J Robot Surg 15(2):155\u2013163. https:\/\/doi.org\/10.1007\/s11701-020-01155-7","DOI":"10.1007\/s11701-020-01155-7"},{"key":"4020_CR23","doi-asserted-by":"publisher","unstructured":"Maharani AJ, Salsabila PL, Radina NI et al (2026) The Robotic Interval Surgery, A Game-Changer in Optimal Debulking for Ovarian Cancer: A Systematic Review and Meta-Analysis. Onco Targets Ther 19:559860. https:\/\/doi.org\/10.2147\/OTT.S559860","DOI":"10.2147\/OTT.S559860"},{"key":"4020_CR24","doi-asserted-by":"publisher","unstructured":"Shi C, Gao Y, Yang Y et al (2019) Comparison of efficacy of robotic surgery, laparoscopy, and laparotomy in the treatment of ovarian cancer: a meta-analysis. World J Surg Oncol 17(1):162. https:\/\/doi.org\/10.1186\/s12957-019-1702-9","DOI":"10.1186\/s12957-019-1702-9"},{"key":"4020_CR25","doi-asserted-by":"publisher","unstructured":"Tang Q, Liu W, Jiang D et al (2022) Perioperative and Survival Outcomes of Robotic-Assisted Surgery, Comparison with Laparoscopy and Laparotomy, for Ovarian Cancer: A Network Meta-Analysis. J Oncol 2022:2084774. https:\/\/doi.org\/10.1155\/2022\/2084774","DOI":"10.1155\/2022\/2084774"},{"key":"4020_CR26","doi-asserted-by":"publisher","unstructured":"Nezhat F, Briskin C, Lakhi N et al (2024) Minimally invasive surgery for the management of ovarian cancer: a systematic review and meta-analysis. O G Open 1(4):39. https:\/\/doi.org\/10.1097\/OG9.0000000000000039","DOI":"10.1097\/OG9.0000000000000039"},{"key":"4020_CR27","doi-asserted-by":"publisher","unstructured":"Yokoi A, Machida H, Shimada M et al (2024) Efficacy and safety of minimally invasive surgery versus open laparotomy for epithelial ovarian cancer: a systematic review and meta-analysis. Gynecol Oncol 190:42\u201352. https:\/\/doi.org\/10.1016\/j.ygyno.2024.08.011","DOI":"10.1016\/j.ygyno.2024.08.011"},{"key":"4020_CR28","doi-asserted-by":"publisher","unstructured":"Rauh-Hain JA, Melamed A, Pareja R et al (2024) Laparoscopic cytoreduction after neoadjuvant chemotherapy in high-grade epithelial ovarian cancer: a LANCE randomized clinical trial. JAMA Netw Open 7(11):e2446325. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.46325","DOI":"10.1001\/jamanetworkopen.2024.46325"},{"key":"4020_CR29","doi-asserted-by":"publisher","unstructured":"Magrina JF, Cetta RL, Chang YH, Guevara G, Magtibay PM (2013) Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy. Gynecol Oncol 129(2):336\u2013340. https:\/\/doi.org\/10.1016\/j.ygyno.2013.01.015","DOI":"10.1016\/j.ygyno.2013.01.015"},{"key":"4020_CR30","doi-asserted-by":"publisher","unstructured":"Conte C, Marchetti C, Loverro M et al (2023) Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer. Int J Gynecol Cancer 33(2):137\u2013144. https:\/\/doi.org\/10.1136\/ijgc-2022-003904","DOI":"10.1136\/ijgc-2022-003904"},{"key":"4020_CR31","doi-asserted-by":"publisher","unstructured":"Certelli C, Russo SA, Palmieri L et al (2023) Minimally-invasive secondary cytoreduction in recurrent ovarian cancer. Cancers (Basel) 15(19):4769. https:\/\/doi.org\/10.3390\/cancers15194769","DOI":"10.3390\/cancers15194769"},{"key":"4020_CR32","doi-asserted-by":"publisher","unstructured":"Lim PC (2022) A review of robotic surgery in the management of recurrent ovarian carcinoma: indication and techniques. Eur J Gynaecol Oncol 43(4):1\u201311. https:\/\/doi.org\/10.22514\/ejgo.2022.030","DOI":"10.22514\/ejgo.2022.030"},{"key":"4020_CR33","doi-asserted-by":"publisher","unstructured":"Gallotta V, Conte C, Giudice MT et al (2018) Secondary laparoscopic cytoreduction in recurrent ovarian cancer: a large, single-institution experience. J Minim Invasive Gynecol 25(4):644\u2013650. https:\/\/doi.org\/10.1016\/j.jmig.2017.10.024","DOI":"10.1016\/j.jmig.2017.10.024"},{"key":"4020_CR34","doi-asserted-by":"publisher","unstructured":"Prat J (2014) Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 124(1):1\u20135. https:\/\/doi.org\/10.1016\/j.ijgo.2013.10.001","DOI":"10.1016\/j.ijgo.2013.10.001"},{"key":"4020_CR35","doi-asserted-by":"publisher","unstructured":"Gallotta V, Certelli C, Oliva R et al (2023) Robotic surgery in ovarian cancer. Best Pract Res Clin Obstet Gynaecol 90:102391. https:\/\/doi.org\/10.1016\/j.bpobgyn.2023.102391","DOI":"10.1016\/j.bpobgyn.2023.102391"},{"key":"4020_CR36","doi-asserted-by":"publisher","unstructured":"Park JY, Bak SE, Song JY et al (2023) Robotic surgery in gynecology: the present and the future. Obstet Gynecol Sci 66(6):518\u2013528. https:\/\/doi.org\/10.5468\/ogs.23132","DOI":"10.5468\/ogs.23132"},{"key":"4020_CR37","doi-asserted-by":"publisher","unstructured":"Lucidi A, Chiantera V, Gallotta V et al (2017) Role of robotic surgery in ovarian malignancy. Best Pract Res Clin Obstet Gynaecol 45:74\u201382. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.05.005","DOI":"10.1016\/j.bpobgyn.2017.05.005"},{"key":"4020_CR38","doi-asserted-by":"publisher","unstructured":"Rabinovich A (2016) Robotic surgery for ovarian cancers: individualization of the surgical approach to select ovarian cancer patients. Int J Med Robot 12(3):547\u2013553. https:\/\/doi.org\/10.1002\/rcs.1684","DOI":"10.1002\/rcs.1684"},{"key":"4020_CR39","doi-asserted-by":"publisher","unstructured":"Aletti GD, Dowdy SC, Podratz KC, Cliby WA (2007) Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol 197(6):676.e1-676.e7. https:\/\/doi.org\/10.1016\/j.ajog.2007.10.495","DOI":"10.1016\/j.ajog.2007.10.495"},{"key":"4020_CR40","doi-asserted-by":"publisher","unstructured":"Fanfani F, Fagotti A, Gallotta V et al (2010) Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery. Gynecol Oncol 116(3):497\u2013501. https:\/\/doi.org\/10.1016\/j.ygyno.2009.11.023","DOI":"10.1016\/j.ygyno.2009.11.023"},{"key":"4020_CR41","doi-asserted-by":"publisher","unstructured":"Matsuo K, Huang Y, Matsuzaki S et al (2020) Minimally invasive surgery and risk of capsule rupture for women with early-stage ovarian cancer. JAMA Oncol 6(7):1110\u20131113. https:\/\/doi.org\/10.1001\/jamaoncol.2020.1702","DOI":"10.1001\/jamaoncol.2020.1702"},{"key":"4020_CR42","doi-asserted-by":"publisher","unstructured":"Matsuo K, Lee AJ, Lee MW et al (2026) Minimally Invasive Surgery, Intraoperative Capsule Rupture, and Survival in Early Ovarian Cancer. JAMA Oncol 12(6):664\u2013666. https:\/\/doi.org\/10.1001\/jamaoncol.2026.0711","DOI":"10.1001\/jamaoncol.2026.0711"},{"key":"4020_CR43","doi-asserted-by":"publisher","unstructured":"Matsuo K, Machida H, Yamagami W et al (2019) Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer. Obstet Gynecol 134(5):1017\u20131026. https:\/\/doi.org\/10.1097\/AOG.0000000000003507","DOI":"10.1097\/AOG.0000000000003507"},{"key":"4020_CR44","doi-asserted-by":"publisher","unstructured":"Ramirez PT, Frumovitz M, Pareja R et al (2018) Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med 379(20):1895\u20131904. https:\/\/doi.org\/10.1056\/NEJMoa1806395","DOI":"10.1056\/NEJMoa1806395"},{"key":"4020_CR45","doi-asserted-by":"publisher","unstructured":"Maggioni A, Benedetti Panici P, Dell\u2019Anna T et al (2006) Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer 95(6):699\u2013704. https:\/\/doi.org\/10.1038\/sj.bjc.6603323","DOI":"10.1038\/sj.bjc.6603323"},{"key":"4020_CR46","doi-asserted-by":"publisher","unstructured":"Park HJ, Kim DW, Yim GW et al (2013) Staging laparoscopy for the management of early-stage ovarian cancer: a metaanalysis. Am J Obstet Gynecol 209(1):58..e1-58.e8 https:\/\/doi.org\/10.1016\/j.ajog.2013.04.013","DOI":"10.1016\/j.ajog.2013.04.013"},{"key":"4020_CR47","doi-asserted-by":"publisher","unstructured":"Falcetta FS, Lawrie TA, Medeiros LR et al (2016) Laparoscopy versus laparotomy for FIGO stage I ovarian cancer. Cochrane Database Syst Rev 10(10):CD005344. https:\/\/doi.org\/10.1002\/14651858.CD005344.pub4","DOI":"10.1002\/14651858.CD005344.pub4"},{"key":"4020_CR48","doi-asserted-by":"publisher","unstructured":"Vergote I, Trop\u00e9 CG, Amant F et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 363(10):943\u2013953. https:\/\/doi.org\/10.1056\/NEJMoa0908806","DOI":"10.1056\/NEJMoa0908806"},{"key":"4020_CR49","doi-asserted-by":"publisher","unstructured":"Kehoe S, Hook J, Nankivell M et al (2015) Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet 386(9990):249\u2013257. https:\/\/doi.org\/10.1016\/S0140-6736(14)62223-6","DOI":"10.1016\/S0140-6736(14)62223-6"},{"key":"4020_CR50","doi-asserted-by":"publisher","unstructured":"Fagotti A, Ferrandina MG, Vizzielli G et al (2020) Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850). Int J Gynecol Cancer 30(11):1657\u20131664. https:\/\/doi.org\/10.1136\/ijgc-2020-001640","DOI":"10.1136\/ijgc-2020-001640"},{"key":"4020_CR51","doi-asserted-by":"publisher","unstructured":"Onda T, Satoh T, Saito T et al (2016) Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III\/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602. Eur J Cancer 64:22\u201331. https:\/\/doi.org\/10.1016\/j.ejca.2016.05.017","DOI":"10.1016\/j.ejca.2016.05.017"},{"key":"4020_CR52","doi-asserted-by":"crossref","unstructured":"Mahner S, Heitz F, Salehi S et al (2025) TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7). J Clin Oncol 43(17suppl):LBA5500. https:\/\/doi.org\/10.1200\/JCO%2E2025%2E43%2E17%5Fsuppl%252ELBA5500","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA5500"},{"key":"4020_CR53","doi-asserted-by":"publisher","unstructured":"Levin G, Agusti N, Beshar I et al (2026) Robotic vs laparoscopic interval cytoreductive surgery in stage III ovarian cancer: an analysis of the National Cancer Database. Int J Gynecol Cancer 36(7):104768. https:\/\/doi.org\/10.1016\/j.ijgc.2026.104768","DOI":"10.1016\/j.ijgc.2026.104768"},{"key":"4020_CR54","doi-asserted-by":"publisher","unstructured":"Harter P, Sehouli J, Vergote I et al (2021) Randomized trial of cytoreductive surgery for relapsed ovarian cancer. N Engl J Med 385(23):2123\u20132131. https:\/\/doi.org\/10.1056\/NEJMoa2103294","DOI":"10.1056\/NEJMoa2103294"},{"key":"4020_CR55","doi-asserted-by":"publisher","unstructured":"Shi T, Zhu J, Feng Y et al (2021) Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1). Lancet Oncol 22(4):439\u2013449. https:\/\/doi.org\/10.1016\/S1470-2045(21)00006-1","DOI":"10.1016\/S1470-2045(21)00006-1"},{"key":"4020_CR56","doi-asserted-by":"publisher","unstructured":"Jiang R, Feng Y, Chen Y et al (2024) Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial. Nat Med 30(8):2181\u20132188. https:\/\/doi.org\/10.1038\/s41591-024-02981-0","DOI":"10.1038\/s41591-024-02981-0"},{"key":"4020_CR57","doi-asserted-by":"publisher","unstructured":"Coleman RL, Spirtos NM, Enserro D et al (2019) Secondary surgical cytoreduction for recurrent ovarian cancer. N Engl J Med 381(20):1929\u20131939. https:\/\/doi.org\/10.1056\/NEJMoa1902626","DOI":"10.1056\/NEJMoa1902626"},{"key":"4020_CR58","doi-asserted-by":"publisher","unstructured":"du Bois A, Fotopoulou C, Gardner GJ et al (2026) Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON). Int J Gynecol Cancer. https:\/\/doi.org\/10.1016\/j.ijgc.2026.104956","DOI":"10.1016\/j.ijgc.2026.104956"},{"key":"4020_CR59","doi-asserted-by":"publisher","unstructured":"Harter P, Sehouli J, Reuss A et al (2011) Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. Int J Gynecol Cancer 21(2):289\u2013295. https:\/\/doi.org\/10.1097\/IGC.0b013e31820aaafd","DOI":"10.1097\/IGC.0b013e31820aaafd"},{"key":"4020_CR60","doi-asserted-by":"publisher","unstructured":"Tian WJ, Chi DS, Sehouli J et al (2012) A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection. Ann Surg Oncol 19(2):597\u2013604. https:\/\/doi.org\/10.1245\/s10434-011-1873-2","DOI":"10.1245\/s10434-011-1873-2"},{"key":"4020_CR61","doi-asserted-by":"publisher","unstructured":"Jiang C, Li Z (2021) Prediction Models for Complete Resection in Secondary Cytoreductive Surgery of Patients With Recurrent Ovarian Cancer. Front Oncol 11:674637. https:\/\/doi.org\/10.3389\/fonc.2021.674637","DOI":"10.3389\/fonc.2021.674637"},{"key":"4020_CR62","doi-asserted-by":"publisher","unstructured":"Oliva R, Rosati A, Certelli C et al (2025) Robotic secondary cytoreduction with 3D reconstruction for isolated recurrent ovarian cancer: a stepwise approach to splenectomy. Ann Surg Oncol 32:4324\u20134325. https:\/\/doi.org\/10.1245\/s10434-025-17183-2","DOI":"10.1245\/s10434-025-17183-2"},{"key":"4020_CR63","doi-asserted-by":"publisher","unstructured":"Bruni S, Schivardi G, Betella I et al (2026) Single-port robotic splenectomy in secondary cytoreduction for recurrent high-grade serous ovarian cancer. Int J Gynecol Cancer 36(5):104482. https:\/\/doi.org\/10.1016\/j.ijgc.2026.104482","DOI":"10.1016\/j.ijgc.2026.104482"},{"key":"4020_CR64","doi-asserted-by":"publisher","unstructured":"Ribero L, Fumagalli D, De Vitis LA et al (2026) Defining surgical fitness in advanced ovarian cancer: a critical review of predictors, algorithms, and pre-habilitation. Int J Gynecol Cancer 36(7):104739. https:\/\/doi.org\/10.1016\/j.ijgc.2026.104739","DOI":"10.1016\/j.ijgc.2026.104739"},{"key":"4020_CR65","doi-asserted-by":"publisher","unstructured":"Baek MH, Park EY, Ha HI et al (2022) Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer: a meta-analysis. J Clin Oncol 40(15):1659\u20131670. https:\/\/doi.org\/10.1200\/JCO.21.02085","DOI":"10.1200\/JCO.21.02085"},{"key":"4020_CR66","doi-asserted-by":"publisher","unstructured":"Bristow RE, Puri I, Chi DS (2009) Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol 112(1):265\u2013274. https:\/\/doi.org\/10.1016\/j.ygyno.2008.08.033","DOI":"10.1016\/j.ygyno.2008.08.033"},{"key":"4020_CR67","doi-asserted-by":"publisher","unstructured":"Al Rawahi T, Lopes AD, Bristow RE et al (2013) Surgical cytoreduction for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev 2CD008765. https:\/\/doi.org\/10.1002\/14651858.CD008765.pub3","DOI":"10.1002\/14651858.CD008765.pub3"},{"key":"4020_CR68","doi-asserted-by":"crossref","unstructured":"Kim NY, Jung DC, Lee JY, Han KH, Oh YT (2021) CT-based Fagotti scoring system for non-invasive prediction of cytoreduction surgery outcome in patients with advanced ovarian cancer. Korean J Radiol 22(9):1481\u20131489. https:\/\/doi.org\/10.3348\/kjr.2020.1477","DOI":"10.3348\/kjr.2020.1477"},{"key":"4020_CR69","doi-asserted-by":"publisher","unstructured":"Fleming ND, Westin SN, Meyer LA et al (2021) Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer. Int J Gynecol Cancer 31(1):92\u201397. https:\/\/doi.org\/10.1136\/ijgc-2020-001718","DOI":"10.1136\/ijgc-2020-001718"},{"key":"4020_CR70","unstructured":"Chereau E, Lavoue V, Ballester M et al (2011) External validation of a laparoscopic-based score to evaluate resectability for patients with advanced ovarian cancer undergoing interval debulking surgery. Anticancer Res 31(12):4469\u20134474"},{"key":"4020_CR71","doi-asserted-by":"publisher","unstructured":"Conte C, Aterno D, Congedo L et al (2026) Minimally invasive interval debulking surgery in advanced ovarian cancer: a real-life PICture of pAtientS\u2019 SelectiOn. Int J Gynecol Cancer 36(5):102844. https:\/\/doi.org\/10.1016\/j.ijgc.2025.102844","DOI":"10.1016\/j.ijgc.2025.102844"},{"key":"4020_CR72","doi-asserted-by":"publisher","unstructured":"Gouy S, Belghiti J, Uzan C, Canlorbe G, Gauthier T, Morice P (2013) Accuracy and reproducibility of the peritoneal cancer index in advanced ovarian cancer during laparoscopy and laparotomy. Int J Gynecol Cancer 23(9):1699\u20131703. https:\/\/doi.org\/10.1097\/IGC.0b013e3182a616a7","DOI":"10.1097\/IGC.0b013e3182a616a7"},{"key":"4020_CR73","doi-asserted-by":"publisher","unstructured":"Noei Teymoordash S, Zendehdel H, Norouzi AR, Kashian M (2025) Diagnostic accuracy of artificial intelligence algorithms to predict remove all macroscopic disease and survival rate after complete surgical cytoreduction in patients with ovarian cancer: a systematic review and meta-analysis. BMC Surg 25(1):27. https:\/\/doi.org\/10.1186\/s12893-025-02766-3","DOI":"10.1186\/s12893-025-02766-3"},{"key":"4020_CR74","doi-asserted-by":"publisher","unstructured":"Luo Q, Wang Y, Zhang X (2025) Association between hospital volume and outcomes in ovarian cancer: a systematic review. Front Surg 12:1635555. https:\/\/doi.org\/10.3389\/fsurg.2025.1635555","DOI":"10.3389\/fsurg.2025.1635555"},{"key":"4020_CR75","doi-asserted-by":"publisher","unstructured":"Bristow RE, Zahurak ML, Diaz-Montes TP, Giuntoli RL, Armstrong DK (2009) Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes. Gynecol Oncol 115(3):334\u2013338. https:\/\/doi.org\/10.1016\/j.ygyno.2009.08.025","DOI":"10.1016\/j.ygyno.2009.08.025"},{"key":"4020_CR76","doi-asserted-by":"publisher","unstructured":"Matsuo K, Chang EJ, Matsuzaki S et al (2020) Minimally invasive surgery for early-stage ovarian cancer: association between hospital surgical volume and short-term perioperative outcomes. Gynecol Oncol 158(1):59\u201365. https:\/\/doi.org\/10.1016\/j.ygyno.2020.04.045","DOI":"10.1016\/j.ygyno.2020.04.045"},{"key":"4020_CR77","doi-asserted-by":"publisher","unstructured":"Magrina JF, Zanagnolo V, Noble BN, Kho RM, Magtibay P (2011) Robotic approach for ovarian cancer: perioperative and survival results and comparison with laparoscopy and laparotomy. Gynecol Oncol 121(1):100\u2013105. https:\/\/doi.org\/10.1016\/j.ygyno.2010.11.045","DOI":"10.1016\/j.ygyno.2010.11.045"},{"key":"4020_CR78","doi-asserted-by":"publisher","unstructured":"Chen CH, Chiu LH, Chen HH, Chan C, Liu WM (2016) Comparison of robotic approach, laparoscopic approach and laparotomy in treating epithelial ovarian cancer. Int J Med Robot 12(2):268\u2013275. https:\/\/doi.org\/10.1002\/rcs.1655","DOI":"10.1002\/rcs.1655"},{"key":"4020_CR79","doi-asserted-by":"publisher","unstructured":"Abitbol J, Kucukyazici B, Brin S et al (2023) Impact of robotic surgery on patient flow and resource use intensity in ovarian cancer. J Robot Surg 17(2):537\u2013547. https:\/\/doi.org\/10.1007\/s11701-022-01447-0","DOI":"10.1007\/s11701-022-01447-0"},{"key":"4020_CR80","doi-asserted-by":"publisher","unstructured":"van Dam GM, Themelis G, Crane LMA et al (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-\u03b1 targeting: first in-human results. Nat Med 17(10):1315\u20131319. https:\/\/doi.org\/10.1038\/nm.2472","DOI":"10.1038\/nm.2472"},{"key":"4020_CR81","doi-asserted-by":"publisher","unstructured":"Tanyi JL, Randall LM, Chambers SK et al (2023) A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006). J Clin Oncol 41(2):276\u2013284. https:\/\/doi.org\/10.1200\/JCO.22.00291","DOI":"10.1200\/JCO.22.00291"},{"key":"4020_CR82","doi-asserted-by":"publisher","unstructured":"Uwins C, Michael A, Skene SS et al (2024) MIRRORS ICG: perfusion assessment using indocyanine green (ICG) peritoneal angiography during robotic interval cytoreductive surgery for advanced ovarian cancer. Cancers (Basel) 16(15):2689. https:\/\/doi.org\/10.3390\/cancers16152689","DOI":"10.3390\/cancers16152689"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-04020-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-026-04020-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-04020-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T01:29:01Z","timestamp":1791768541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-026-04020-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4020"],"URL":"https:\/\/doi.org\/10.1007\/s11701-026-04020-1","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"31 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this article is a review and does not involve original research involving human participants or animals, ethical approval was not required.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, generative artificial intelligence was used only for the AI-assisted reconstruction of mechanistic schematic figures.","order":3,"name":"Ethics","label":"Artificial intelligence use","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1078"}}